Anticancer Effects of New Compounds in Rats
Author Information
Author(s): T. Klenner, M.R. Berger, G. Eisenbrand, D. Schmahl
Primary Institution: German Cancer Research Center
Hypothesis
The study investigates the anticancer efficacy of 2-chloroethylnitrosocarbamoyl derivatives of L-alanine and glycine against rat mammary carcinoma.
Conclusion
The glycine derivatives showed superior anticancer activity compared to the L-alanine derivatives.
Supporting Evidence
- The glycine derivatives significantly inhibited tumor volume and number compared to controls.
- CNC-gly was the most effective compound, leading to a significant increase in life span.
- Free amino acid derivatives showed higher activity than dipeptides and tripeptides.
- Significant differences in tumor numbers were found at week 6 for treated groups.
Takeaway
Scientists tested new cancer-fighting drugs on rats with breast cancer, and found that some worked better than others.
Methodology
The study involved inducing mammary carcinomas in rats and administering various compounds to assess their effects on tumor volume and survival.
Limitations
The study's findings may not directly translate to human cancer treatment due to differences in tumor biology.
Participant Demographics
Virgin female Sprague-Dawley rats were used in the study.
Statistical Information
P-Value
p<0.05
Confidence Interval
95%
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website